Quality signals in a medicine access service

Creator: Reserve Meds
Published: 2026-04-20

The positive signs that a service is careful with your medicine, your money and your information.

Reviewed by the Reserve Meds clinical operations team on 18 October 2026. Sources accessed 18 October 2026.

The short answer

A careful medicine access service names the licensed company that supplies the medicine, documents the chain of custody and temperature, insists on a prescription from your treating doctor, gives you a written quote and a written timeline estimate before you commit, and asks for your consent before sharing your information.

Licensed supply: a named supplier whose licence you can check.
Documented custody: traceable packs and a temperature record.
Your doctor in charge: prescription and medical decisions stay with your doctor.
Written terms: quote, timeline estimate, refunds and privacy in writing.

Signal 1: a supplier you can check

US wholesale drug distributors and third-party logistics providers must be appropriately licensed and must report their licensure to the FDA every year to count as authorized trading partners under that law. The FDA publishes the reports in a searchable database that is updated every business day. A listing is not an FDA licence or approval in itself: the licence is issued by the state, and the database helps you see that a company has reported one.^[1]

A careful service tells you who the supplier is without being chased, and explains what that company is licensed to do.

Signal 2: chain of custody that is documented

In the United States, the Drug Supply Chain Security Act sets out an electronic, interoperable way to identify and trace certain prescription medicines at the package level as they move through the supply chain, to keep harmful products out and to find and remove them quickly if they get in.^[2]

WHO's good storage and distribution practices note that medical products face risks at every stage, from purchasing and storage to repackaging, relabelling, transport and distribution, and that many different people and organizations handle them along the way.^[3]

In practice this means the service can tell you how the medicine is traced, how it is packed and monitored, and who checks the record when it arrives.

Signal 3: the treating doctor stays in charge

The FDA's advice to consumers is that a legitimate seller of prescription medicines always requires a doctor's prescription, and that a seller who does not ask for one is a warning sign.^[4]

A careful service supports your doctor with paperwork, but never offers to prescribe, change a dose or decide whether a medicine is right for you.

Signal 4: everything important is in writing

A written quote that lists each part separately, before you commit.
A written timeline estimate that explains which steps depend on the regulator or hospital.
Written refund and cancellation terms.
A written privacy notice that says who sees your documents and why.

Signal 5: consent and privacy are taken seriously

In the UAE, Federal Decree-Law No. 45 of 2021 on the Protection of Personal Data prohibits processing personal data without the owner's consent, apart from limited cases, gives people the right to ask for corrections and to restrict or stop processing, and sets requirements for sending personal data across borders. It came into force on 2 January 2022.^[5]

Saudi Arabia issued its Personal Data Protection Law in September 2021, and the Saudi Data and AI Authority's national data governance platform lets individuals file a complaint about the handling of their personal data.^[6]

A careful service asks for your consent before it shares your documents with a hospital, regulator or supplier, and only shares what each step needs.

Signal 6: honest limits

A careful service tells you when a route will not work, when a medicine is investigational and needs a manufacturer program instead, or when another route, such as treatment at a center abroad, fits your case better.

Investigational medicines are a different route. In the US, expanded access needs the agreement of a licensed physician, an Institutional Review Board and the company that makes the product; without the company's cooperation there is no access.^[7]

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We coordinate the route with your treating doctor and hospital, prepare the paperwork the regulator or hospital asks for, and arrange supply once approval is in place. Your doctor prescribes and makes every medical decision. You can ask us for our wholesale partner's licence details, and you get your quote and timeline estimate in writing before you commit.

We coordinate access to FDA-approved medicines only. Investigational medicines are only available through a manufacturer's expanded-access program requested by the treating physician; we can explain that route, but we do not supply them. Your coordination fee is quoted in writing for your case before you commit. No hidden charges. We give you a written timeline estimate for your case before you commit.

Ask us about a medicine

Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.

Frequently asked questions

What is the single most useful signal?

A named supplier whose licence you can check, together with written terms. Both are easy to ask for and hard to fake.

Should the service ever prescribe?

No. A legitimate seller of prescription medicines requires a prescription from your doctor, and your doctor makes the medical decisions.

Why does consent matter?

In the UAE, the personal data protection law prohibits processing personal data without the owner's consent, apart from limited cases. A careful service asks first.

Is it a good sign if a service says no?

Often, yes. A service that declines a case it cannot handle safely is protecting you.

Sources for these answers: ^{[1, 4, 5]}

Sources

All sources were opened and checked on 18 October 2026. Rules and labels change, so the treating hospital or regulator confirms the current position before anything is filed.

US FDA: Annual Licensure Reporting by Wholesale Drug Distributors and Third-Party Logistics Providers (accessed 18 October 2026)
US FDA: Drug Supply Chain Security Act (DSCSA) (content current as of 16 October 2025) (accessed 18 October 2026)
World Health Organization: TRS 1025, Annex 7, Good storage and distribution practices for medical products (17 June 2020) (accessed 18 October 2026)
US FDA: How to Buy Medicines Safely From an Online Pharmacy (content current as of 2 January 2025) (accessed 18 October 2026)
UAE Government portal (u.ae): Data protection laws, Federal Decree-Law No. 45 of 2021 on the Protection of Personal Data (accessed 18 October 2026)
Saudi Data and AI Authority (SDAIA): National Data Governance Platform, Personal Data Protection Law (accessed 18 October 2026)
US FDA: Expanded Access, Information for Patients (accessed 18 October 2026)

This page is general information, not medical or legal advice. It does not replace advice from your own doctor or the regulator.